ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 177382 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 177382; 2) Community: the network communities that were significantly associated with the response to NSC 177382; 3) Molecule: the relationships between components within communities and NSC 177382; 4) MDR: the compounds that were significantly associated with the NSC 177382.

NSC Compound Enrichment Correlation
NSC 715481 Null 0.0392716453377535 0.058422801
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0392716453377535 0.029728874
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0392716453377535 0.072308888
NSC 725098 Null 0.0392716453377535 0.12290346
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.14708269
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0392716453377535 -0.17540639
NSC 732205 Null 0.0392716453377535 0.0033515449
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0392716453377535 -0.11566719
NSC 744688 Null 0.0392716453377535 -0.05089326
NSC 750050 Null 0.0392716453377535 -0.069069889
Total:59  Current:49    [First] [Prev] [Next] [Last]